Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study

Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study. Duthoit, Guillaume; Silvain, Johanne; Marijon, Eloi; Ducrocq, Grégory; Lepillier, Antoine; Frere, Corinne; Dimby, Solohaja-Faniaha; Popovic, Batric; Lellouche, Nicolas; Martin-Toutain, Isabelle; Spaulding, Christian; Brochet, Eric; Attias, David; Mansourati, Jacques; Lorgis, Luc; Klug, Didier; Zannad, Noura; Hauguel-Moreau, Marie; Braik, Nassim; Deltour, Sandrine; Ceccaldi, Alexandre; Wang, Hui; Hammoudi, Nadjib; Brugier, Delphine; Vicaut, Eric; Juliard, Jean-Michel; Montalescot, Gilles. Circulation. Cardiovascular Interventions. 2020; 13: p.e008481. doi:10.1161/CIRCINTERVENTIONS.119.008481
Article